Amy C Justice1,2,3, Kathleen A McGinnis2, Janet P Tate1, Ke Xu1,2, William C Becker1,2, Hongyu Zhao1,3, Joel Gelernter1,2, Henry R Kranzler4. 1. Yale School of Medicine, New Haven, Connecticut. 2. Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut. 3. Yale School of Public Health, New Haven, Connecticut. 4. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN 4 MIRECC, Crescenz VAMC, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Although alcohol risk is heritable, few genetic risk variants have been identified. Longitudinal electronic health record (EHR) data offer a largely untapped source of phenotypic information for genetic studies, but EHR-derived phenotypes for harmful alcohol exposure have yet to be validated. Using a variant of known effect, we used EHR data to develop and validate a phenotype for harmful alcohol exposure that can be used to identify unknown genetic variants in large samples. Herein, we consider the validity of 3 approaches using the 3-item Alcohol Use Disorders Identification Test consumption measure (AUDIT-C) as a phenotype for harmful alcohol exposure. METHODS: First, using longitudinal AUDIT-C data from the Veterans Aging Cohort Biomarker Study Cohort (VACS-BC), we compared 3 metrics of AUDIT-C using correlation coefficients: (i) AUDIT-C closest to blood sampling (closest AUDIT-C), (ii) the highest value (highest AUDIT-C), (iii) and longitudinal trajectories generated using joint trajectory modeling (AUDIT-C trajectory). Second, we compared the associations of the 3 AUDIT-C metrics with phosphatidylethanol (PEth), a direct, quantitative biomarker for alcohol in the overall sample using chi-square tests for trend. Last, in the subsample of African Americans (AAs; n = 1,503), we compared the associations of the 3 AUDIT-C metrics with rs2066702 a common missense (Arg369Cys) polymorphism of the ADH1B gene, which encodes an alcohol dehydrogenase isozyme. RESULTS: The sample (n = 1,851, 94.5% male, 65% HIV+, mean age 52 years) had a median of 7 AUDIT-C scores over a median of 6.1 years. Highest AUDIT-C and AUDIT-C trajectory were correlated r = 0.86. The closest AUDIT-C was obtained a median of 2.26 years after the VACS-BC blood draw. Overall and among AAs, all 3 AUDIT-C metrics were associated with PEth (all p < 0.05), but the gradient was steepest with AUDIT-C trajectory. Among AAs (36% with the protective ADH1B allele), the association of rs2066702 with AUDIT-C trajectory and highest AUDIT-C was statistically significant (p < 0.05), and the gradient was steeper for the AUDIT-C trajectory than for the highest AUDIT-C. The closest AUDIT-C was not statistically significantly associated with rs2066702. CONCLUSIONS: EHR data can be used to identify complex phenotypes such as harmful alcohol use. The validity of the phenotype may be enhanced through the use of longitudinal trajectories.
BACKGROUND: Although alcohol risk is heritable, few genetic risk variants have been identified. Longitudinal electronic health record (EHR) data offer a largely untapped source of phenotypic information for genetic studies, but EHR-derived phenotypes for harmful alcohol exposure have yet to be validated. Using a variant of known effect, we used EHR data to develop and validate a phenotype for harmful alcohol exposure that can be used to identify unknown genetic variants in large samples. Herein, we consider the validity of 3 approaches using the 3-item Alcohol Use Disorders Identification Test consumption measure (AUDIT-C) as a phenotype for harmful alcohol exposure. METHODS: First, using longitudinal AUDIT-C data from the Veterans Aging Cohort Biomarker Study Cohort (VACS-BC), we compared 3 metrics of AUDIT-C using correlation coefficients: (i) AUDIT-C closest to blood sampling (closest AUDIT-C), (ii) the highest value (highest AUDIT-C), (iii) and longitudinal trajectories generated using joint trajectory modeling (AUDIT-C trajectory). Second, we compared the associations of the 3 AUDIT-C metrics with phosphatidylethanol (PEth), a direct, quantitative biomarker for alcohol in the overall sample using chi-square tests for trend. Last, in the subsample of African Americans (AAs; n = 1,503), we compared the associations of the 3 AUDIT-C metrics with rs2066702 a common missense (Arg369Cys) polymorphism of the ADH1B gene, which encodes an alcohol dehydrogenase isozyme. RESULTS: The sample (n = 1,851, 94.5% male, 65% HIV+, mean age 52 years) had a median of 7 AUDIT-C scores over a median of 6.1 years. Highest AUDIT-C and AUDIT-C trajectory were correlated r = 0.86. The closest AUDIT-C was obtained a median of 2.26 years after the VACS-BC blood draw. Overall and among AAs, all 3 AUDIT-C metrics were associated with PEth (all p < 0.05), but the gradient was steepest with AUDIT-C trajectory. Among AAs (36% with the protective ADH1B allele), the association of rs2066702 with AUDIT-C trajectory and highest AUDIT-C was statistically significant (p < 0.05), and the gradient was steeper for the AUDIT-C trajectory than for the highest AUDIT-C. The closest AUDIT-C was not statistically significantly associated with rs2066702. CONCLUSIONS: EHR data can be used to identify complex phenotypes such as harmful alcohol use. The validity of the phenotype may be enhanced through the use of longitudinal trajectories.
Authors: Kathleen A McGinnis; Amy C Justice; Kevin L Kraemer; Richard Saitz; Kendall J Bryant; David A Fiellin Journal: Alcohol Clin Exp Res Date: 2012-10-10 Impact factor: 3.455
Authors: Andrew J Barnes; Alison A Moore; Haiyong Xu; Alfonso Ang; Louise Tallen; Michelle Mirkin; Susan L Ettner Journal: J Gen Intern Med Date: 2010-04-16 Impact factor: 5.128
Authors: Friedrich M Wurst; Natasha Thon; Michel Yegles; Alexandra Schrück; Ulrich W Preuss; Wolfgang Weinmann Journal: Alcohol Clin Exp Res Date: 2015-09-07 Impact factor: 3.455
Authors: L J Bierut; A M Goate; N Breslau; E O Johnson; S Bertelsen; L Fox; A Agrawal; K K Bucholz; R Grucza; V Hesselbrock; J Kramer; S Kuperman; J Nurnberger; B Porjesz; N L Saccone; M Schuckit; J Tischfield; J C Wang; T Foroud; J P Rice; H J Edenberg Journal: Mol Psychiatry Date: 2011-10-04 Impact factor: 15.992
Authors: Andrew J Rosato; Xiaochun Chen; Yoshiaki Tanaka; Lindsay A Farrer; Henry R Kranzler; Yaira Z Nunez; David C Henderson; Joel Gelernter; Huiping Zhang Journal: Epigenomics Date: 2019-05-29 Impact factor: 4.778
Authors: Amy C Justice; Rachel V Smith; Janet P Tate; Kathleen McGinnis; Ke Xu; William C Becker; Kuang-Yao Lee; Kevin Lynch; Ning Sun; John Concato; David A Fiellin; Hongyu Zhao; Joel Gelernter; Henry R Kranzler Journal: Addiction Date: 2018-08-01 Impact factor: 6.526
Authors: Kirsha S Gordon; Kathleen McGinnis; Cecilia Dao; Christopher T Rentsch; Aeron Small; Rachel Vickers Smith; Rachel L Kember; Joel Gelernter; Henry R Kranzler; Kendall J Bryant; Janet P Tate; Amy C Justice Journal: AIDS Behav Date: 2020-02
Authors: Kathleen A McGinnis; Amy C Justice; Janet P Tate; Henry R Kranzler; Hilary A Tindle; William C Becker; John Concato; Joel Gelernter; Boyang Li; Xinyu Zhang; Hongyu Zhao; Kristina Crothers; Ke Xu Journal: Addict Biol Date: 2018-10-04 Impact factor: 4.280
Authors: Oghenowede Eyawo; Kathleen A McGinnis; Amy C Justice; David A Fiellin; Judith A Hahn; Emily C Williams; Adam J Gordon; Brandon D L Marshall; Kevin L Kraemer; Stephen Crystal; Julie R Gaither; E Jennifer Edelman; Kendall J Bryant; Janet P Tate Journal: J Acquir Immune Defic Syndr Date: 2018-02-01 Impact factor: 3.731
Authors: Henry R Kranzler; Hang Zhou; Rachel L Kember; Rachel Vickers Smith; Amy C Justice; Scott Damrauer; Philip S Tsao; Derek Klarin; Aris Baras; Jeffrey Reid; John Overton; Daniel J Rader; Zhongshan Cheng; Janet P Tate; William C Becker; John Concato; Ke Xu; Renato Polimanti; Hongyu Zhao; Joel Gelernter Journal: Nat Commun Date: 2019-04-02 Impact factor: 14.919
Authors: Kara M Bensley; Kathleen A McGinnis; David A Fiellin; Adam J Gordon; Kevin L Kraemer; Kendall J Bryant; E Jennifer Edelman; Stephen Crystal; Julie R Gaither; P Todd Korthuis; Brandon D L Marshall; India J Ornelas; K C Gary Chan; Julia C Dombrowski; John C Fortney; Amy C Justice; Emily C Williams Journal: Addict Sci Clin Pract Date: 2018-01-22
Authors: Falk W Lohoff; Toni-Kim Clarke; Zachary A Kaminsky; Rosie M Walker; Mairead L Bermingham; Jeesun Jung; Stewart W Morris; Daniel Rosoff; Archie Campbell; Miruna Barbu; Katrin Charlet; Mark Adams; Jisoo Lee; David M Howard; Emma M O'Connell; Heather Whalley; David J Porteous; Andrew M McIntosh; Kathryn L Evans Journal: Mol Psychiatry Date: 2021-12-02 Impact factor: 13.437